NH
This startup offers metabolomic testing to identify underlying metabolic imbalances in individuals with treatment-resistant depression. By analyzing a patient's unique metabolic profile, the test aims to provide insights that can inform personalized and more effective treatment strategies.
Pittsburgh, United States5+ followers
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- This startup offers metabolomic testing to identify underlying metabolic imbalances in individuals with treatment-resistant depression. By analyzing a patient's unique metabolic profile, the test aims to provide insights that can inform personalized and more effective treatment strategies.